Clinical Trials on Lateral Canthal Lines (LCL)

Total 946 results

Galderma R&D

Completed

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination (READY-3)

Glabellar Frown Lines (GL) | Lateral Canthal Lines (LCL)

United States, Canada
Eirion Therapeutics Inc.

Active, not recruiting

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Crow's Feet | Lateral Canthal Lines, LCL

United States
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Crow's Feet | Lateral Canthal Lines, LCL

United States
Medy-Tox

Completed

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Russian Federation, Germany, Canada, Belgium, United Kingdom
Medy-Tox

Completed

MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada
Medy-Tox

Completed

MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada, United Kingdom
Allergan

Completed

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Lateral Canthal Lines | Crow's Feet Lines

Korea, Republic of
Allergan

Completed

BOTOX® in the Treatment of Crow's Feet Lines in China

Lateral Canthal Lines | Crow's Feet Lines

China
Galderma R&D

Completed

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines (READY-4)

Lateral Canthal Lines | Glabellar Lines

United States, Puerto Rico
Smith & Nephew, Inc.

Completed

BIOSURE™ RG Knee Safety & Performance Study

ACL Repair | Posterior Cruciate Ligament (PCL) Repair | Medial Collateral Ligament (MCL) | Lateral Collateral Ligament (LCL) | Posterior Oblique Ligament (POL) | Patellar Realignment and Tendon Repairs | Vastus Medialis Obliquus Advancement | Iliotibial Band Tenodesis | Extra-capsular Repairs | Knee Repair

United States
Medy-Tox

Completed

MT10109L in the Treatment of Lateral Canthal Lines

Lateral Canthal Lines

United States, Russian Federation, United Kingdom
Galderma R&D

Completed

Treatment of Moderate to Severe Lateral Canthal Lines (READY-2)

Lateral Canthal Lines

United States, Canada
Medy-Tox

Completed

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines

Lateral Canthal Lines

Australia
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines

Lateral Canthal Lines

United States
Ipsen

Completed

Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)

Lateral Canthal Lines

France, Germany, United Kingdom
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-208

Lateral Canthal Lines | Crow's Feet

United States
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-207

Lateral Canthal Lines | Crow's Feet

United States
Croma-Pharma GmbH

Completed

Princess® RICH for the Correction of Fine Lines (RICH)

Lateral Canthal Lines | Perioral Rhytids

Austria
Anterios Inc.

Completed

Clinical Trial to Evaluate ANT-1401 in Crow's Feet

Lateral Canthal Lines | Crows Feet

United States
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines

Lateral Canthal Lines | Crow's Feet

United States
Anterios Inc.

Completed

Dose Finding Study In Subjects With Crow's Feet

Lateral Canthal Lines | Crow's Feet

United States
Anterios Inc.

Completed

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

Lateral Canthal Lines | Crow's Feet

United States
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines

Crow's Feet Lines | Lateral Canthus Rhytides

Belgium, Canada, United States, United Kingdom
Allergan

Completed

BOTOX® in the Treatment of Crow's Feet Lines in Japan

Crow's Feet Lines | Lateral Canthus Rhytides

Japan
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)

United States, Canada
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Lateral Canthal Lines

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Lateral Canthal Lines

United States
Merz North America, Inc.
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines (ULTRA I)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

United States
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines. (ULTRA II)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

Germany
Revance Therapeutics, Inc.

Completed

Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Galderma R&D

Completed

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Glabellar Frown Lines | Canthal Lines

United States
Galderma R&D

Completed

A Multi-Center Study Of CD07743 for the Improvement of Lateral Canthal Lines (CROW'S FEET)

Canthal Lines
Merz North America, Inc.

Terminated

Longitudinal Evaluation and Real-world Evidence of NT201

Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face

United States
Infoscitex Corporation
Mayo Clinic; U.S. Army Medical Research and Development Command

Completed

Evaluation of the Development of an Advanced, Conformable Prosthetic Socket, Study II

Evaluation of a New Prosthetic Socket Liner Material

United States
Infoscitex Corporation
Mayo Clinic; U.S. Army Medical Research and Development Command

Completed

Evaluation of the Development of an Advanced, Conformable Prosthetic Socket, Study I

Evaluation of a New Prosthetic Socket Liner Material.

United States
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

GIMEMA CLL0809 Study (BendOfa) (BendOfa)

Patients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines

Italy
University of Texas Southwestern Medical Center
Gus Gear Inc

Recruiting

Exploration of Central Venous Catheter Protective Devices in the Pediatric Population: A Mixed Methods Study

Central Line

United States
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Study Dynamic Haptic Robotic Trainer (DHRT) and DHRT+ for CVC Insertion Training for Surgical Residents

Central Line Complication | Central Line Infection

United States
Sohag University

Completed

Comparison Between Supraclavicular And Infraclavicular Approach For Right Subclavian Venous Catheterization

Central Line Complication

Egypt
University of British Columbia

Completed

CVAD-Associated Skin Impairment in Allogeneic Stem Cell Transplant Recipients: Dressing vs No-Dressing

Central Line Complication

Canada
Brno University Hospital

Completed

Central Venous Catheters in Pediatric Anesthesia and Intensive Care (PEDCVC)

Central Line

Czechia
Institute of Medical Sciences and SUM Hospital

Completed

Short Versus Long Axis Ultrasound Guided Approach for Internal Jugular Vein Cannulations

Ultrasonography | Central Line Complication

India
Mahidol University

Unknown

Self-invented Intracavitary ECG Wire VS the Commercial System - Certodyn® (iECG)

Central Line Complication

Thailand
Hackensack Meridian Health

Active, not recruiting

Central Venous Access Study (CASCADE)

Central Line Catheters

United States
Lawson Health Research Institute
University of Western Ontario, Canada

Completed

Virtual Reality With Ultrasound Versus Ultrasound For Central Line Insertion

Central Line Complication

Canada

Clinical Trials on Lateral Canthal Lines (LCL)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations